Tecan Group AG (LON:0QLN)

Market Cap	1.53B
Revenue (ttm)	832.06M
Net Income (ttm)	57.94M
Shares Out	n/a
EPS (ttm)	4.54
PE Ratio	26.44
Forward PE	18.47
Dividend	2.79 (2.17%)
Ex-Dividend Date	Apr 14, 2025

Volume	552
Average Volume	20,478
Open	127.75
Previous Close	128.80
Day's Range	127.75 - 129.00
52-Week Range	120.99 - 245.20
Beta	1.28
RSI	39.33
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF